M. Naglak et al., WHAT TO CONSIDER WHEN CONDUCTING A COST-EFFECTIVENESS ANALYSIS IN A CLINICAL SETTING, Journal of the American Dietetic Association, 98(10), 1998, pp. 1149-1154
More data are needed providing strong evidence that nutrition services
are cost-effective. Economic evaluations, such as cost-effectiveness
analyses, are excellent practice-based research projects. We conducted
a cost-effectiveness analysis in a clinical setting to compare the co
st-effectiveness of lipid-lowering medications plus diet therapy (medi
cation+diet) with diet therapy alone (diet alone) for treating patient
s with hypercholesterolemia. Twenty-five adults with hypercholesterole
mia (13 receiving medication+diet, 12 receiving diet alone) either par
ticipated in an 8-week, home-based, step 1 intervention or were counse
led about diet and lifestyle by their care provider. Diet, cost, and l
aboratory data were collected at baseline, at 9 months, and at 19 mont
hs after participation in the intervention (follow-up). Cost per unit
change in outcome was evaluated for each group. The diet-alone group m
ade only small changes in dietary Intake, changes that were smaller in
magnitude than those made by the medication+diet group. Nevertheless,
at 9 months, costs per unit change in total serum cholesterol level a
nd low-density lipoprotein cholesterol (LDL-C) level were approximatel
y $24 and $83 less, respectively, for the diet-alone group. At follow-
up, however, the cost per unit change in LDL-C level was approximately
$17 less for the medication+diet group, which can be explained by the
medication+diet group's greater decrease in LDL-C level. The followin
g elements should be considered when conducting a cost-effectiveness a
nalysis of medical nutrition therapy: effectiveness of the nutrition i
ntervention, adequate sample size, confounding variables, compliance w
ith diet and drug therapy, direct and indirect costs of care, and foll
ow-up evaluation.